Dysregulated T Cell–Mediated Immunity Underlies Progression of Arrhythmogenic Right Ventricular Cardiomyopathy
Article Details
Authors (13)
Alexandros Protonotarios
Institute of Cardiovascular Science, University College London, United Kingdom (A.P., I.H., P.S., P.M.E.).
Silvia Fanti
William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.F., F.M.-B.).
Barbara Szomolay
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Imogen Heenan
Institute of Cardiovascular Science, University College London, United Kingdom (A.P., I.H., P.S., P.M.E.).
Angeliki Asimaki
Cardiovascular and Genomics Research institute, School of Health & Medical Sciences, City St George’s University of London, United Kingdom (A.A., J.W., E.R.B., M.N.S.).
Joseph Westaby
Cardiovascular and Genomics Research institute, School of Health & Medical Sciences, City St George’s University of London, United Kingdom (A.A., J.W., E.R.B., M.N.S.).
Elijah R. Behr
Mary N. Sheppard
Cardiovascular and Genomics Research institute, School of Health & Medical Sciences, City St George’s University of London, United Kingdom (A.A., J.W., E.R.B., M.N.S.).
Stefania Rizzo
Cristina Basso
Petros Syrris
Institute of Cardiovascular Science, University College London, United Kingdom (A.P., I.H., P.S., P.M.E.).
Federica Marelli-Berg
William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.F., F.M.-B.).
Perry M. Elliott
Institute of Cardiovascular Science, University College London, United Kingdom (A.P., I.H., P.S., P.M.E.).